Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.89965 | 38 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.83427 | 37 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.8381 | 37 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.72436 | 34 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.78097 | 36 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.94193 | 38 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.86314 | 35 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.79792 | 36 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.79808 | 36 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.78958 | 35 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.82415 | 36 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.80733 | 37 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.83306 | 36 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.8907 | 39 |